Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis
- PMID: 21336465
- PMCID: PMC6549837
- DOI: 10.4104/pcrj.2011.00007
Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis
Abstract
The British Thoracic Society (BTS) has recently published a guideline for the management of non-cystic fibrosis (non-CF) bronchiectasis in children and adults. This paper summarises the key recommendations applicable to the primary care setting. The key points are: • Think of the diagnosis of bronchiectasis in adults and children who present with a chronic productive cough or unexplained haemoptysis, and in children with asthma which responds poorly to treatment; • High resolution computed tomography (HRCT) scanning is needed to confirm the diagnosis • Sputum culture should be obtained at the start of an exacerbation prior to initiating treatment with antibiotics; Treatment should be started whilst awaiting the sputum result and should be continued for 14 days; • Patients with bronchiectasis have significant morbidity. Management in primary care is aimed at improving morbidity, and includes; patient education, treatment and monitoring, as well as appropriate referral to secondary care including assessment for long term antibiotics.
Conflict of interest statement
None
Comment in
-
Bronchiectasis: why the diagnosis shouldn't be missed in primary care.Prim Care Respir J. 2011 Jun;20(2):107-8. doi: 10.4104/pcrj.2011.00047. Prim Care Respir J. 2011. PMID: 21597661 Free PMC article. No abstract available.
Similar articles
-
Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019.NPJ Prim Care Respir Med. 2019 Jun 27;29(1):24. doi: 10.1038/s41533-019-0136-8. NPJ Prim Care Respir Med. 2019. PMID: 31249313 Free PMC article. Review.
-
British Thoracic Society national bronchiectasis audit 2010 and 2011.Thorax. 2012 Oct;67(10):928-30. doi: 10.1136/thoraxjnl-2012-201983. Epub 2012 Jul 17. Thorax. 2012. PMID: 22807516
-
Bronchiectasis: why the diagnosis shouldn't be missed in primary care.Prim Care Respir J. 2011 Jun;20(2):107-8. doi: 10.4104/pcrj.2011.00047. Prim Care Respir J. 2011. PMID: 21597661 Free PMC article. No abstract available.
-
Updated BTS Adult Bronchiectasis Guideline 2018: a multidisciplinary approach to comprehensive care.Thorax. 2019 Jan;74(1):1-3. doi: 10.1136/thoraxjnl-2018-212468. Thorax. 2019. PMID: 30545946
-
British Thoracic Society guideline for non-CF bronchiectasis.Thorax. 2010 Jul;65 Suppl 1:i1-58. doi: 10.1136/thx.2010.136119. Thorax. 2010. PMID: 20627931 Review.
Cited by
-
Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis.Mediators Inflamm. 2014;2014:708608. doi: 10.1155/2014/708608. Epub 2014 Nov 4. Mediators Inflamm. 2014. PMID: 25580060 Free PMC article. Clinical Trial.
-
Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.Open Respir Med J. 2015 Mar 31;9:46-51. doi: 10.2174/1874306401509010046. eCollection 2015. Open Respir Med J. 2015. PMID: 25893025 Free PMC article.
-
Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.NPJ Prim Care Respir Med. 2017 Mar 13;27(1):18. doi: 10.1038/s41533-017-0019-9. NPJ Prim Care Respir Med. 2017. PMID: 28270656 Free PMC article. Review.
-
Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis.Mediators Inflamm. 2015;2015:642503. doi: 10.1155/2015/642503. Epub 2015 Dec 27. Mediators Inflamm. 2015. PMID: 26819500 Free PMC article.
-
Bronchiectasis: a bacteriological profile.Pan Afr Med J. 2015 Dec 17;22:378. doi: 10.11604/pamj.2015.22.378.7775. eCollection 2015. Pan Afr Med J. 2015. PMID: 27047618 Free PMC article.